FG Orders Withdrawal Of Contaminated Children’s Ibuprofen Suspension, Levamisole Drugs Over Brain Damage Risk

In a circular dated June 4, 2026, and addressed to Chief Medical Directors (CMDs) and Medical Directors (MDs) of health institutions, the Federal Ministry of Health and Social Welfare directed healthcare providers to suspend the purchase and use of the affected medicines and report any adverse reactions associated with them to the National Agency for Food and Drug Administration and Control (NAFDAC).